This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board approves standalone Sep 2026 quarter: revenue up 111%, profit up 158%, margin narrows
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 Sep 2026: revenue from operations rose 111% to Rs 710.54 lakh from Rs 337.08 lakh; net profit rose 158% to Rs 91.82 lakh from Rs 35.63 lakh a year earlier. EBITDA margin fell from 16.8% to 11.8%. Half year ended 30 Sep 2026 versus 2025: standalone revenue Rs 1,209.27 lakh versus Rs 1,047.62 lakh; net profit Rs 127.45 lakh versus Rs 133.33 lakh. No exceptional items or borrowings; related-party dealings disclosed.
Strong quarterly growth and zero borrowings are positive, but the narrower EBITDA margin and slightly lower half-year profit may limit stock gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹7.11 Cr | ₹12.09 Cr | −41.2% |
| Operating profit | ₹0.74 Cr | ₹0.90 Cr | −18.2% |
| Profit after tax | ₹0.92 Cr | ₹0.71 Cr | +30.1% |
| EBITDA margin | 11.8% | 8.4% | +3.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.